Form 8-K - Current report:
SEC Accession No. 0001104659-23-037467
Filing Date
2023-03-28
Accepted
2023-03-28 09:40:15
Documents
15
Period of Report
2023-03-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2310656d1_8k.htm   iXBRL 8-K 38201
2 EXHIBIT 10.1 tm2310656d1_ex10-1.htm EX-10.1 90811
3 EXHIBIT 99.1 tm2310656d1_ex99-1.htm EX-99.1 15603
7 GRAPHIC tm2310656d1_ex99-1img001.jpg GRAPHIC 40418
  Complete submission text file 0001104659-23-037467.txt   408231

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mxct-20230327.xsd EX-101.SCH 3031
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mxct-20230327_lab.xml EX-101.LAB 34477
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mxct-20230327_pre.xml EX-101.PRE 22594
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2310656d1_8k_htm.xml XML 3702
Mailing Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878
Business Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40674 | Film No.: 23766586
SIC: 8731 Services-Commercial Physical & Biological Research